tiprankstipranks
NovoCure Ltd. (NVCR)
NASDAQ:NVCR
US Market
NVCR
NovoCure
RESEARCH TOOLSreports

NovoCure (NVCR) Income Statement

Compare
1,574 Followers

NovoCure Income Statement

Last quarter (Q4 2025), NovoCure's total revenue was $174.35M, an increase of 8.11% from the same quarter last year. In Q4, NovoCure's net income was $-24.50M. See NovoCure’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 655.35M$ 605.22M$ 509.34M$ 537.84M$ 535.03M
Gross Profit
$ 488.47M$ 468.04M$ 381.06M$ 422.97M$ 420.15M
Operating Expenses
$ 642.27M$ 638.53M$ 614.67M$ 512.50M$ 464.49M
Depreciation and Amortization
$ 17.20M$ 11.23M$ 10.97M$ 10.62M$ 10.25M
EBITDA
$ -119.05M$ -109.58M$ -177.45M$ -67.89M$ -38.38M
Operating Income
$ -153.80M$ -170.50M$ -232.87M$ -89.52M$ -44.33M
Other Income/Expenses
$ 17.55M$ 39.33M$ 41.13M$ 7.68M$ -7.74M
Pretax Income
$ -136.25M$ -131.16M$ -191.74M$ -81.85M$ -52.08M
Net Income
$ -136.23M$ -168.63M$ -207.04M$ -92.53M$ -58.35M
Per Share Metrics
Basic EPS
$ -1.22$ -1.56$ -1.95$ -0.88$ -0.56
Diluted EPS
$ -1.22$ -1.56$ -1.95$ -0.88$ -0.56
Weighted Average Shares Outstanding
 111.47M 107.83M 106.39M 104.66M 103.43M
Weighted Average Shares Outstanding (Diluted)
 111.47M 107.83M 106.39M 104.66M 103.43M
Currency in USD

NovoCure Earnings and Revenue History